The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases.

Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, 33 North Drive, Building 33, Room 2E19A.2, Bethesda, MD 20892, USA.
Journal of Virology (Impact Factor: 4.65). 08/2011; 85(22):12067-72. DOI: 10.1128/JVI.05559-11
Source: PubMed

ABSTRACT Cleavage of the flavivirus prM protein by a cellular furin-like protease is a hallmark of virion maturation. While this cleavage is a required step in the viral life cycle, it can be inefficient. Virions that retain uncleaved prM may be infectious. We investigated whether cleavage by furin of prM on partially mature West Nile virus (WNV) during virus entry contributes to infectivity. Using quantitative assays of WNV infection, we found that virions incorporating considerable amounts of uncleaved prM protein were insensitive to treatment of cells with a potent inhibitor of furin activity. Thus, partially mature WNV does not require furin-like proteases for infectivity.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Only a small fraction of influenza A virus (IAV) particles within a viral population register as infectious by traditional infectivity assays. Despite constituting the most abundant product of influenza infection, the role that the 'noninfectious' particle fraction plays in the biology of the virus has largely been ignored. This review shines a light on this oft-ignored population by highlighting studies, both old and new, that describe the unique biological activities of these particles, and discussing what this population can tell us about the biology of IAV evolution and disease.
    Future Virology 01/2014; 9(1):41-51. DOI:10.2217/fvl.13.118 · 1.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: West Nile virus (WNV) is an emerging zoonotic mosquito-borne flavivirus responsible for outbreaks of febrile illness and meningoencephalitis. The replication of WNV takes place on virus-modified membranes from the endoplasmic reticulum of the host cell and virions acquire their envelope by budding into this organelle. Consistent with this view, the cellular biology of this pathogen is intimately ligated to modifications of the intracellular membranes, and the requirement of specific lipids such as cholesterol and fatty acids has been documented. In this study, we evaluated the impact of WNV infection on two important components of cellular membranes, glycerophospholipids and sphingolipids, by mass spectrometry of infected cells. A significant increase in the content of several glycerophospholipids (phosphatidylcholine, plasmalogens and lysophospholipids) and sphingolipids (ceramide, dihidroceramide and sphingomyelin) was noticed in WNV-infected cells, suggesting functional roles of these lipids during WNV infection. Furthermore, the analysis of the lipid envelope of WNV virions and recombinant virus-like particles revealed a unique composition of their envelopes that were enriched in sphingolipids (sphingomyelin) and showed reduced levels of phosphatidylcholine, in a manner similar to that of sphingolipid enriched lipid microdomains. Inhibition of neutral sphingomyelinase (which catalyzes the hydrolysis of sphingomyelin into ceramide), either by pharmacological approaches or siRNA mediated silencing, reduced the release of flavivirus virions as well as virus-like particles, suggesting a role of sphingomyelin to ceramide conversion in flavivirus budding and confirming the importance of sphingolipids in the biogenesis of WNV.
    Journal of Virology 08/2014; 88(20):12041-12054. DOI:10.1128/JVI.02061-14 · 4.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The DenV pre-membrane protein (prM) is a crucial chaperone for the viral envelope protein, preventing premature fusion with vesicles during viral export. prM molecules in immature particles are cleaved by host proteases, leading to mature fusogenic virions. Blockade of prM cleavage would restrict fusion and represents a novel druggable opportunity against DenV. We have thus established a cell-based platform to monitor prM processing that relies on an engineered two-tag scaffold that travels to the cell surface through the secretory pathway. The assay discriminates between a single cell-surface tag when prM is cleaved and two tags when it is not, as detected through fluorescent-coupled antibodies by flow cytometry. The assay, miniaturized into a 96-well plate format, was multiplexed with the HIV-1 envelope boundary, also cleaved in the same pathway. A pilot screen against 1280 compounds was executed, leading to the identification of a potential active and corroborating the robustness of our assay for large-scale screening. We describe for the first time a cell-based assay that monitors DenV prM processing within the classical secretory pathway, which was exploited to identify a potential novel drug against DenV.
    Journal of Biomolecular Screening 02/2015; DOI:10.1177/1087057115571247 · 2.01 Impact Factor

Full-text (2 Sources)

Available from
May 17, 2014